entacapone [Ligand Id: 6647] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL953 (Comtan, Comtess, Entacapone, Entacapone orion, Entacapone teva, OR-611)
  • Alpha-ketoglutarate-dependent dioxygenase FTO in Human [ChEMBL: CHEMBL2331065] [UniProtKB: Q9C0B1]
There should be some charts here, you may need to enable JavaScript!
  • Catechol-O-methyltransferase/Catechol O-methyltransferase in Human [ChEMBL: CHEMBL2023] [GtoPdb: 2472] [UniProtKB: P21964]
  • Catechol-O-methyltransferase/Catechol O-methyltransferase in Rat [ChEMBL: CHEMBL2372] [GtoPdb: 2472] [UniProtKB: P22734]
There should be some charts here, you may need to enable JavaScript!
There should be some charts here, you may need to enable JavaScript!
  • mitochondrial pyruvate carrier 2 in Human [GtoPdb: 3023] [UniProtKB: O95563]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
Alpha-ketoglutarate-dependent dioxygenase FTO in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2331065] [UniProtKB: Q9C0B1]
ChEMBL Inhibition of FTO (unknown origin) demethylation activity B 5.46 pIC50 3500 nM IC50 J Med Chem (2021) 64: 16974-17003 [PMID:34792334]
ChEMBL Inhibition of FTO (unknown origin) assessed as reduction in demethylation by measuring N6-mA and A level incubated for 2 hrs by HPLC-MS/MS analysis B 5.52 pIC50 3000 nM IC50 US-20180118665-A1. FTO inhibitors (2018)
Catechol-O-methyltransferase/Catechol O-methyltransferase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2023] [GtoPdb: 2472] [UniProtKB: P21964]
GtoPdb membrane-bound enzyme - 8.7 pKi 2 nM Ki Biochemistry (1995) 34: 4202-10 [PMID:7703232]
GtoPdb soluble enzyme - 9.52 pKi 0.3 nM Ki Biochemistry (1995) 34: 4202-10 [PMID:7703232]
ChEMBL Inhibition of human recombinant His-tagged soluble COMT expressed in Escherichia coli BL21 using aesculetin as substrate after 60 mins by microplate assay in presence of SAM B 6.41 pIC50 386 nM IC50 J Med Chem (2016) 59: 4664-4675 [PMID:27074629]
ChEMBL Inhibition of COMT (unknown origin) in presence of AdoMet and Esculetin by reaction kinetic model based assay relative to control B 7.22 pIC50 60 nM IC50 US-20180118665-A1. FTO inhibitors (2018)
Catechol-O-methyltransferase/Catechol O-methyltransferase in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2372] [GtoPdb: 2472] [UniProtKB: P22734]
ChEMBL Inhibitory activity against COMT in rat brain B 4.89 pIC50 12800 nM IC50 J Med Chem (2005) 48: 8070-8078 [PMID:16335931]
ChEMBL Inhibitory activity against COMT in rat liver B 5.63 pIC50 2320 nM IC50 J Med Chem (2005) 48: 8070-8078 [PMID:16335931]
ChEMBL Inhibition of rat liver COMT using esculetin as substrate by fluorescence based spectrophotometry B 6.64 pIC50 230 nM IC50 Bioorg Med Chem Lett (2020) 30: 127188-127188 [PMID:32299731]
ChEMBL Inhibition of S-COMT in Wistar rat liver assessed as metanephrine formation preincubated for 20 mins followed by addition of adrenaline as substrate and SAM measured after 5 mins by chromatographic analysis B 7.46 pIC50 34.45 nM IC50 J Med Chem (2016) 59: 7584-7597 [PMID:27463695]
ChEMBL Inhibition of Catechol O-methyltransferase activity in rat brain B 7.89 pIC50 12.8 nM IC50 J Med Chem (2002) 45: 685-695 [PMID:11806720]
ChEMBL Inhibition of MB-COMT in Wistar rat brain assessed as metanephrine formation preincubated for 20 mins followed by addition of adrenaline as substrate and SAM measured after 15 mins by chromatographic analysis B 8.46 pIC50 3.47 nM IC50 J Med Chem (2016) 59: 7584-7597 [PMID:27463695]
ChEMBL Inhibition of MB-COMT in Wistar rat brain assessed as metanephrine formation preincubated for 20 mins followed by addition of adrenaline as substrate and SAM measured after 15 mins by chromatographic analysis B 8.52 pIC50 3.02 nM IC50 J Med Chem (2016) 59: 7584-7597 [PMID:27463695]
GPR35/G-protein coupled receptor 35 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1293267] [GtoPdb: 102] [UniProtKB: Q9HC97]
ChEMBL Agonist activity at GPR35 in human U2OS cells assessed as induction of beta-arrestin translocation after 5 hrs by beta-lactamase reporter gene assay B 4.18 pEC50 65600 nM EC50 Medchemcomm (2012) 3: 1270-1274
ChEMBL Agonist activity at GPR35 in human HT-29 cells assessed as induction of whole cell dynamic mass redistribution after 50 mins by resonant waveguide grating biosensor analysis B 5.25 pEC50 5660 nM EC50 Medchemcomm (2012) 3: 1270-1274
mitochondrial pyruvate carrier 2 in Human [GtoPdb: 3023] [UniProtKB: O95563]
GtoPdb - - 6.22 pIC50 600 nM IC50 Mol Metab (2022) 60: 101469 [PMID:35278701]

ChEMBL data shown on this page come from version 34:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]